Duncan Williams Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
1,290
+15
+1% +$15.3K 0.35% 41
2026
Q1
$1.17M Sell
1,275
-24
-2% -$24.3K 0.33% 43
2025
Q4
$1.44M Buy
1,299
+916
+239% +$876K 0.36% 37
2025
Q3
$292K Buy
383
+55
+17% +$40.9K 0.08% 134
2025
Q2
$256K Buy
328
+75
+30% +$58.3K 0.08% 136
2025
Q1
$209K Buy
+253
New +$211K 0.08% 136
2024
Q4
Sell
-247
Closed -$219K 151
2024
Q3
$219K Buy
+247
New +$222K 0.12% 117

Other funds holding LLY

Duncan Williams Asset Management's LLY Position: Q2 2026 in Review

Duncan Williams Asset Management increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $15.3K and bringing the position to 1,290 shares worth $1.55M. The position accounts for 0.35% of the portfolio, ranked #41.

Duncan Williams Asset Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Duncan Williams Asset Management held 1,290 shares of Eli Lilly worth $1.55M as of Q2 2026.
  • Duncan Williams Asset Management bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.35% of Duncan Williams Asset Management's portfolio in Q2 2026, its #41 holding.
  • Duncan Williams Asset Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.